News All news Engineering cleantech medtech Software mobility Events Startups fintech news Biotech Science & Education Image news September 29th, 2026 Switzerland ranks 1st in the Global Innovation Index 2026 for the 16th consecutive year Most popular Month Year Image medtech Say goodbye to needles for blood glucose monitoring Image medtech New PCR test device from ETH Zurich spin-off in the starting blocks Image news Swiss impact in the global AI renaissance Image medtech Innovations in wound healing: from good bacteria to mechanical reprogramming of tissue Image medtech Say goodbye to needles for blood glucose monitoring Image medtech New PCR test device from ETH Zurich spin-off in the starting blocks Image news Swiss impact in the global AI renaissance Image medtech Innovations in wound healing: from good bacteria to mechanical reprogramming of tissue Pagination First page First Previous page Page 1 Page 2 Page 3 Page 4 Partners feed Image - startupticker.ch Switzerland Shines as a Deep Tech Hub at CES 2026 Image - startupticker.ch €13.9 million for glucose-monitoring wearable Image - startupticker.ch Enlightra raises USD 15 million M to tackle the biggest bottleneck in AI infrastructure Image - startupticker.ch Neural Concept closes $100M funding round to scale AI-Native engineering Image - startupticker.ch FoRx Therapeutics raises $50 million to advance clinical trials Image - startupticker.ch Los Angeles cloud production studio acquires PRODUCER Image - startupticker.ch Swiss-US startup HomeBuddy acquired for $190 million Image - startupticker.ch SK Capital acquires majority stake in Swixx Biopharma at EUR 1.5 billion valuation Image - startupticker.ch Swiss delegation warms up for CES 2026 in Las Vegas Load More
Image news September 29th, 2026 Switzerland ranks 1st in the Global Innovation Index 2026 for the 16th consecutive year
Image - startupticker.ch Enlightra raises USD 15 million M to tackle the biggest bottleneck in AI infrastructure
Image - startupticker.ch SK Capital acquires majority stake in Swixx Biopharma at EUR 1.5 billion valuation
